Regulatory T Cells Ameliorate Intrauterine Growth Retardation in a Transgenic Rat Model for Preeclampsia

Hypertension

Volumn 65, Issue 6, 2015, Pages 1298-1306

  Przybyl, Lukasz ^a   Ibrahim, Tarek ^b   Haase, Nadine ^a   Golic, Michaela ^a   Rugor, Julianna ^a   Luft, Friedrich C ^a   Bendix, Ivo ^c   Serdar, Meray ^c   Wallukat, Gerd ^a   Staff, Anne Cathrine ^d   Müller, Dominik N ^a   Hünig, Thomas ^e   Felderhoff Müser, Ursula ^c   Herse, Florian ^a   Lamarca, Babette ^b   Dechend, Ralf ^a,f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Center for Excellence in Cardiovascular Renal Research   (United States)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f HELIOS Klinikum   (Germany)

Author keywords

fetal growth retardation; preeclampsia; pregnancy; T lymphocytes, regulatory

Indexed keywords

ANGIOTENSIN RECEPTOR; AUTOANTIBODY; CD28 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JJ316; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; BRAIN DEVELOPMENT; BRAIN LIVER WEIGHT RATIO; BRAIN SIZE; CD4+ T LYMPHOCYTE; CIRCULATION; CONTROLLED STUDY; FEMALE; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; NONHUMAN; PLACENTA; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; RAT; RAT MODEL; REGULATORY T LYMPHOCYTE; TRANSGENIC RAT; UPREGULATION; ANIMAL; BREEDING; DISEASE MODEL; DRUG EFFECTS; FETAL GROWTH RETARDATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY OUTCOME; RANDOMIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; LYMPHOCYTE ACTIVATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, ANIMAL; RANDOM ALLOCATION; RATS; RATS, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 84937561878     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04892     Document Type: Article

References (41)

1. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:11221131. doi: 10.1097/01.AOG.0000437382.03963.88.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644. doi: 10.1016/S0140-6736(10)60279-6.
3. Barker DJ, Fall CH. Fetal and infant origins of cardiovascular disease. Arch Dis Child. 1993;68:797-799.
4. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63:534-543. doi: 10.1111/j.1600-0897.2010.00831.x.
5. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266-271. doi: 10.1038/ni1037.
6. Clark DA, Chaouat G. Regulatory T cells and reproduction: how do they do it? J Reprod Immunol. 2012;96:1-7. doi: 10.1016/j.jri.2012.07.007.
7. Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, Saito S. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol. 2010;85:121-129. doi: 10.1016/j.jri.2010.02.006.
8. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod. 2004;10:347-353. doi: 10.1093/molehr/gah044.
9. Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol Cell Biol. 2010;88:615-617. doi: 10.1038/icb.2010.68.
10. Steinborn A, Schmitt E, Kisielewicz A, Rechenberg S, Seissler N, Mahnke K, Schaier M, Zeier M, Sohn C. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol. 2012;167:84-98. doi: 10.1111/j.1365-2249.2011.04493.x.
11. Wang WJ, Liu FJ, Xin-Liu, Hao CF, Bao HC, Qu QL, Liu XM. Adoptive transfer of pregnancy-induced CD4+CD25+ regulatory T cells reverses the increase in abortion rate caused by interleukin 17 in the CBA/JxBALB/c mouse model. Hum Reprod. 2014;29:946-952. doi: 10.1093/humrep/deu014.
12. Dechend R, Gratze P, Wallukat G, Shagdarsuren E, Plehm R, Bräsen JH, Fiebeler A, Schneider W, Caluwaerts S, Vercruysse L, Pijnenborg R, Luft FC, Müller DN. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension. 2005;45:742-746. doi: 10.1161/01.HYP.0000154785.50570.63.
13. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996;274:995-998.
14. Verlohren S, Geusens N, Morton J, Verhaegen I, Hering L, Herse F, Dudenhausen JW, Muller DN, Luft FC, Cartwright JE, Davidge ST, Pijnenborg R, Dechend R. Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension. 2010;56:304-310. doi: 10.1161/HYPERTENSIONAHA.110.153163.
15. Hering L, Herse F, Geusens N, Verlohren S, Wenzel K, Staff AC, Brosnihan KB, Huppertz B, Luft FC, Muller DN, Pijnenborg R, Cartwright JE, Dechend R. Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hypertension. 2010;56:311-318. doi: 10.1161/HYPERTENSIONAHA.110.150961.
16. Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S, Gratze P, Dechend R, Luft FC, Muller DN. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation. 2009;119:2904-2912. doi: 10.1161/CIRCULATIONAHA.108.832782.
17. Hünig T, Dennehy K. CD28 superagonists: mode of action and therapeutic potential. Immunol Lett. 2005;100:21-28. doi: 10.1016/j. imlet.2005.06.012.
18. Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, Hanke T, Hünig T, Kerkau T, Gold R. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med. 2005;202:445-455. doi: 10.1084/jem.20051060.
19. Geusens N, Hering L, Verlohren S, Luyten C, Drijkoningen K, Taube M, Vercruysse L, Hanssens M, Dechend R, Pijnenborg R. Changes in endovascular trophoblast invasion and spiral artery remodelling at term in a transgenic preeclamptic rat model. Placenta. 2010;31:320-326. doi: 10.1016/j.placenta.2010.01.011.
20. Tacke M, Hanke G, Hanke T, Hünig T. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur J Immunol. 1997;27:239-247. doi: 10.1002/eji.1830270136.
21. Scherjon S, Lashley L, van der Hoorn ML, Claas F. Fetus specific T cell modulation during fertilization, implantation and pregnancy. Placenta. 2011;32(suppl 4):S291-S297. doi: 10.1016/j.placenta.2011.03.014.
22. Paeschke S, Chen F, Horn N, Fotopoulou C, Zambon-Bertoja A, Sollwedel A, Zenclussen ML, Casalis PA, Dudenhausen JW, Volk HD, Zenclussen AC. Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am J Reprod Immunol. 2005;54:384-389. doi: 10.1111/j.1600-0897.2005.00334.x.
23. Kim YM, Romero R, Oh SY, Kim CJ, Kilburn BA, Armant DR, Nien JK, Gomez R, Mazor M, Saito S, Abrahams VM, Mor G. Toll-like receptor 4: a potential link between "danger signals," the innate immune system, and preeclampsia? Am J Obstet Gynecol. 2005;193(3 Pt 2):921-927. doi: 10.1016/j.ajog.2005.07.076.
24. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, Kotsch K, Leber J, Volk HD. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol. 2005;166:811-822. doi: 10.1016/S0002-9440(10)62302-4.
25. Reid MV, Murray KA, Marsh ED, Golden JA, Simmons RA, Grinspan JB. Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol. 2012;71:640-653. doi: 10.1097/NEN.0b013e31825cfa81.
26. Tolcos M, Bateman E, ODowd R, Markwick R, Vrijsen K, Rehn A, Rees S. Intrauterine growth restriction affects the maturation of myelin. Exp Neurol. 2011;232:53-65. doi: 10.1016/j.expneurol.2011.08.002.
27. Wallace K, Novotny S, Heath J, Moseley J, Martin JN Jr, Owens MY, LaMarca B. Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol. 2012;303:R144-R149. doi: 10.1152/ajpregu.00049.2012.
28. Novotny SR, Wallace K, Heath J, Moseley J, Dhillon P, Weimer A, Wallukat G, Herse F, Wenzel K, Martin JN Jr, Dechend R, Lamarca B. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol. 2012;302:R1197-R1201. doi: 10.1152/ajpregu.00623.2011.
29. Fujio K, Okamura T, Sumitomo S, Yamamoto K. Regulatory T cellmediated control of autoantibody-induced inflammation. Front Immunol. 2012;3:28. doi: 10.3389/fimmu.2012.00028.
30. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L, Muller DN, Luft FC, Staff AC. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension. 2007;49:604-611. doi: 10.1161/01.HYP.0000257797.49289.71.
31. Cipolla MJ, Pusic AD, Grinberg YY, Chapman AC, Poynter ME, Kraig RP. Pregnant serum induces neuroinflammation and seizure activity via TNFα. Exp Neurol. 2012;234:398-404. doi: 10.1016/j.expneurol.2012.01.005.
32. Johnson AC, Tremble SM, Chan SL, Moseley J, LaMarca B, Nagle KJ, Cipolla MJ. Magnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia. PLoS One. 2014;9:e113670. doi: 10.1371/journal.pone.0113670.
33. Girardi G, Fraser J, Lennen R, Vontell R, Jansen M, Hutchison G. Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (uspio) -conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development [published online ahead of print September 23, 2014]. Mol Psychiatry. doi: 10.1038/mp.2014.110. http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2014110a.html. Accessed March 26, 2015.
34. Wenzel K, Rajakumar A, Haase H, et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension. 2011;58:77-84. doi: 10.1161/HYPERTENSIONAHA.111.171348.
35. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med. 2008;14:855-862. doi: 10.1038/nm.1856.
36. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87-92.
37. Thadhani R, Kisner T, Hagmann H, et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation. 2011;124:940-950. doi: 10.1161/CIRCULATIONAHA.111.034793.
38. Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2015;8:80-93. doi: 10.1038/mi.2014.44.
39. Schilderink R, Verseijden C, de Jonge WJ. Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol. 2013;4:226. doi: 10.3389/fimmu.2013.00226.
40. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006;355:1018-1028. doi: 10.1056/NEJMoa063842.
41. Tabares P, Berr S, Römer PS, Chuvpilo S, Matskevich AA, Tyrsin D, Fedotov Y, Einsele H, Tony HP, Hünig T. Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08. Eur J Immunol. 2014;44:1225-1236. doi: 10.1002/eji.201343967.